NASDAQ
Eupraxia Pharmaceuticals Inc. (EPRX) has a current ratio of 15.12x as of Monday, May 25, 2026. This represents a 90.85% increase compared to its 12-month average of 7.92x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.